Fact sheet: Parvest EqWdHthCre

Fund information

Fund name
Parvest Equity World Health Care Classic Cap EUR
Fund company manager
BNP Paribas Asset Management L
Fund type
SIB
Fund manager
Jon Stephenson
since 02/05/2016
Fund objective
Increase the value of its assets over the medium term.
Benchmark
MSCI World [S] Health Care 10/40 (NR)
Investment style
None
Investment method
Shares

Performance snapshot

Quick stats

1 Year return

2.47 %

1 Year rank in sector

23/29

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 319.3 m

FE Risk score

151

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    65.35%
  • Switzerland
    8.65%
  • Ireland
    8.04%
  • UK
    7.06%
  • Germany
    6.35%
  • Pharmaceuticals
    45.79%
  • Biotechnology/Medical
    23.48%
  • Health Care
    15.97%
  • Healthcare & Medical Products
    14.77%
  • US Equities
    65.35%
  • UK Equities
    9.46%
  • Swiss Equities
    8.65%
  • Irish Equities
    8.04%
  • German Equities
    6.35%

Performance vs. Sector

Cumulative performance

1m6m1y3y5y
Fund-2.15 %5.81 %2.47 %34.92 %96.72 %
Sector1.98 %12.69 %10.38 %31.15 %105.72 %
Rank within sector26 / 3025 / 2923 / 2910 / 2614 / 23
Quartile th4 th4 th4 th2 nd3 rd

Calendar performance

YTD-20172016201520142013
Fund6.47 %-8.75 %15.07 %34.91 %31.67 %
Sector15.76 %-9.92 %7.24 %28.08 %41.03 %
Rank within sector25 / 2913 / 295 / 2711 / 2418 / 23
Quartile th4 th2 nd1 st2 nd4 th

Risk statistics

Alpha2.11
Beta1.03
Sharpe0.41
Volatility17.66
Tracking error7.28
Information ratio0.29
R-Squared0.82

Price movement

52 week high995.53
52 week low804.23
Current bid price0
Current offer price0
Current mid price950.2

Holdings by region

  • 65.35% USA
  • 8.65% Switzerland
  • 8.04% Ireland
  • 7.06% UK
  • 6.35% Germany
  • 2.4% Jersey
  • 2.15% Japan

Holdings by sector

  • 45.79% Pharmaceuticals
  • 23.48% Biotechnology/Medical
  • 15.97% Health Care
  • 14.77% Healthcare & Medical Products

Holdings by asset type

  • 65.35% US Equities
  • 9.46% UK Equities
  • 8.65% Swiss Equities
  • 8.04% Irish Equities
  • 6.35% German Equities
  • 2.15% Japanese Equities

Individual holdings

  • 7.29% UNITEDHEALTH GROUP INC
  • 5.99% MERCK & CO INC(NEW)
  • 5.74% CELGENE CORP
  • 5.5% ALLERGAN INC
  • 4.48% LILLY (ELI) & CO
  • 4.24% BOSTON SCIENTIFIC CORP
  • 4.17% EDWARDS LIFESCIENCES CORP
  • 3.99% NOVARTIS AG
  • 3.91% JAZZ PHARMACEUTICALS PLC
  • 3.69% ROCHE HLDG AG